Sandra T. van Tiel

1.8k citations

53 papers · 1.4k indexed · h-index 22

Molecular Biology
Oncology top 10%
Biomedical Engineering top 10%
Biomaterials top 5%
Pulmonary and Respiratory Medicine top 10%

Co-authors: Timo L.M. ten Hagen Ann L.B. Seynhaeve A.M.M. Eggermont Johannes H. W. de Wilt Alexander M.M. Eggermont E. A. de Bruijn Alexander Eggermont Monique R. Bernsen
Topics: Immunotherapy and Immune Responses (10 papers)Angiogenesis and VEGF in Cancer (10 papers)Sarcoma Diagnosis and Treatment (10 papers)
Cited by: Biomaterials Immunology and Allergy Oncology
Journals: PLoS ONE JNCI Journal of the National Cancer Institute Cancer Research
Partner nations: Netherlands Belgium Spain

In The Last Decade

Sandra T. van Tiel

53 papers receiving 1.4k citations

Peers

Countries citing papers authored by Sandra T. van Tiel

Since Specialization

Citations

This map shows the geographic impact of Sandra T. van Tiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra T. van Tiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra T. van Tiel more than expected).

Fields of papers citing papers by Sandra T. van Tiel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra T. van Tiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra T. van Tiel. The network helps show where Sandra T. van Tiel may publish in the future.

Co-authorship network of co-authors of Sandra T. van Tiel

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra T. van Tiel. A scholar is included among the top collaborators of Sandra T. van Tiel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra T. van Tiel. Sandra T. van Tiel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Peripheral blood monocyte and synovial macrophage subsets in the mouse model of osteoarthritis induced by destabilization of the medial meniscus 2019 ·Osteoarthritis and Cartilage ·Lizette Utomo,Niamh Fahy,Nicole Kops,Sandra T. van Tiel,J.H. Waarsing,Jan A.N. Verhaar,Pieter J. M. Leenen,Gerjo J. V. M. van Osch,Y.M. Bastiaansen-Jenniskens	1
2	In Vivo Stabilized SB3, an Attractive GRPR Antagonist, for Pre- and Intra-Operative Imaging for Prostate Cancer 2018 ·Molecular Imaging and Biology ·(unknown),Sandra T. van Tiel,Joost Haeck,Gabriela N. Doeswijk,Erik de Blois,Marcel Segbers,Θεοδοσία Μάινα,Berthold A. Nock,Marion de Jong,Simone U. Dalm	14
3	SPIO labeling of endothelial cells using ultrasound and targeted microbubbles at diagnostic pressures 2018 ·PLoS ONE ·Ilya Skachkov,Ying Luan,Sandra T. van Tiel,Antonius F.W. van der Steen,Nico de Jong,Monique R. Bernsen,Klazina Kooiman	3
4	Imaging inflammation in the knee joint with 111IN-octreoscan 2016 ·Osteoarthritis and Cartilage ·Sandra T. van Tiel,Lizette Utomo,(unknown),(unknown),Monique R. Bernsen,Y.M. Bastiaansen-Jenniskens	2
5	Nanoparticles and clinically applicable cell tracking 2015 ·British Journal of Radiology ·Monique R. Bernsen,(unknown),Sandra T. van Tiel,Gabriël P. Krestin	29
6	Magnetic Resonance Detection of CD34+ Cells from Umbilical Cord Blood Using a 19F Label 2015 ·PLoS ONE ·Lucia Duinhouwer,(unknown),Sandra T. van Tiel,(unknown),Gabriela N. Doeswijk,Joost Haeck,(unknown),(unknown),Gyula Kotek,Eric Braakman,Jan J. Cornelissen,Monique R. Bernsen	7
7	Basal cell carcinomas without histological confirmation and their treatment: an audit in four European regions 2012 ·British Journal of Dermatology ·S.C. Flohil,Charlotte M. Proby,(unknown),Sandra T. van Tiel,Olli Saksela,Sari Pitkänen,(unknown),R. Micallef,Esther de Vries,(unknown)	17
8	Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo 2008 ·Biochemical and Biophysical Research Communications ·Eric Farrell,Piotr A. Wielopolski,(unknown),Sandra T. van Tiel,Holger Jahr,Jan A.N. Verhaar,Harrie Weinans,Gabriël P. Krestin,Fergal J. O’Brien,Gerjo van Osch,Monique R. Bernsen	119
9	Tumor Necrosis Factor α Mediates Homogeneous Distribution of Liposomes in Murine Melanoma that Contributes to a Better Tumor Response 2007 ·Cancer Research ·Ann L.B. Seynhaeve,Saske Hoving,Debby Schipper,(unknown),(unknown),Sandra T. van Tiel,Alexander Eggermont,Timo L.M. ten Hagen	142
10	Early destruction of tumor vasculature in tumor necrosis factor-α-based isolated limb perfusion is responsible for tumor response 2006 ·Anti-Cancer Drugs ·Saske Hoving,Ann L.B. Seynhaeve,Sandra T. van Tiel,(unknown),E. A. de Bruijn,Alexander Eggermont,Timo L.M. ten Hagen	30
11	Gene Therapy in In Vivo Isolated Perfusion Models 2005 ·Current Gene Therapy ·Boudewijn van Etten,Alexander M.M. Eggermont,Sandra T. van Tiel,(unknown),Johannes H.W. de Wilt,Timo Hagen	9
12	Dynamic contrast-enhanced MRI using macromolecular contrast media for monitoring the response to isolated limb perfusion in experimental soft-tissue sarcomas 2004 ·Magnetic Resonance Materials in Physics Biology and Medicine ·Adrian Preda,Piotr A. Wielopolski,Timo L.M. ten Hagen,(unknown),Jifke F. Veenland,(unknown),Sandra T. van Tiel,Mika W. Vogel,Alexander M.M. Eggermont,Gabriël P. Krestin,Cornelis F. van Dijke	17
13	Synergistic Antitumor Activity of Histamine Plus Melphalan in Isolated Limb Perfusion: Preclinical Studies 2004 ·JNCI Journal of the National Cancer Institute ·Flávia Brunstein,Saske Hoving,Ann L.B. Seynhaeve,Sandra T. van Tiel,G. Guetens,E. A. de Bruijn,Alexander M.M. Eggermont,Timo L.M. ten Hagen	32
14	Tumor necrosis factor‐α augmented tumor response in B16BL6 melanoma‐bearing mice treated with stealth liposomal doxorubicin (Doxil®) correlates with altered Doxil® pharmacokinetics 2004 ·International Journal of Cancer ·Peter Brouckaert,Nozomi Takahashi,Sandra T. van Tiel,Jeroen Hostens,Alexander Eggermont,Ann L.B. Seynhaeve,Walter Fiers,Timo L.M. ten Hagen	42
15	Lack of efficacy of Doxil® in TNF-α-based isolated limb perfusion in sarcoma-bearing rats 2004 ·British Journal of Cancer ·Timo L.M. ten Hagen,Saske Hoving,(unknown),Sandra T. van Tiel,A.M.M. Eggermont	3
16	Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF-α-based isolated hepatic perfusion 2003 ·British Journal of Cancer ·Boudewijn van Etten,Mark R. de Vries,Marc G. A. van Ijken,Titia E. Lans,G. Guetens,(unknown),Sandra T. van Tiel,Gert De Boeck,E. A. de Bruijn,Alexander M.M. Eggermont,Timo L.M. ten Hagen	39
17	Isolated limb perfusion with actinomycin D and TNF-alpha results in improved tumour response in soft-tissue sarcoma-bearing rats but is accompanied by severe local toxicity 2002 ·British Journal of Cancer ·Ann L.B. Seynhaeve,Johannes H. W. de Wilt,Sandra T. van Tiel,A.M.M. Eggermont,Timo L.M. ten Hagen	23
18	Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions 2000 ·British Journal of Cancer ·Johannes H. W. de Wilt,Eric R. Manusama,Boudewijn van Etten,Sandra T. van Tiel,Anita S. Jorna,Ann L.B. Seynhaeve,Timo L.M. ten Hagen	40
19	Low-dose tumor necrosis factor-α augments antitumor activity of stealth liposomal doxorubicin (DOXIL®) in soft tissue sarcoma-bearing rats 2000 ·International Journal of Cancer ·Timo L.M. ten Hagen,A.H. van der Veen,Peet Nooijen,Sandra T. van Tiel,Ann L.B. Seynhaeve,Alexander Eggermont	67
20	TNF- α augments intratumoural concentrations of doxorubicin in TNF- α -based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects 2000 ·British Journal of Cancer ·A.H. van der Veen,Johannes H. W. de Wilt,A.M.M. Eggermont,Sandra T. van Tiel,Ann L.B. Seynhaeve,Timo L.M. ten Hagen	123

About Sandra T. van Tiel

Sandra T. van Tiel is a scholar working on Immunology and Allergy, Immunology and Hematology, having authored 53 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), Angiogenesis and VEGF in Cancer (10 papers) and Sarcoma Diagnosis and Treatment (10 papers). The work is most often cited by research in Biomaterials (283 citations), Immunology and Allergy (111 citations) and Oncology (438 citations). Sandra T. van Tiel has collaborated with scholars based in Netherlands, Belgium and Spain. Frequent co-authors include Timo L.M. ten Hagen, Ann L.B. Seynhaeve, A.M.M. Eggermont, Johannes H. W. de Wilt, Alexander M.M. Eggermont, E. A. de Bruijn, Alexander Eggermont, Monique R. Bernsen, A.H. van der Veen and Saske Hoving. Their work appears in journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact